Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 6/20 | 0.60 |
| ▸ | CHRNA4 | P43681 | 6/20 | 0.60 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31677367 | 0.82 | CHRNB2 (0.57) | CHRNB2CHRNA4ORAI1 | |
| SCHEMBL30471555 | 0.81 | CHRNB2 (0.51) | CHRNB2CHRNA4ORAI1MAPTRAB9A | |
| SCHEMBL938253 | 0.81 | CHRNB2 (0.51) | CHRNB2CHRNA4ORAI1MAPTRAB9A | |
| SCHEMBL3266596 | 0.79 | CHRNB2 (0.62) | CHRNB2CHRNA4ORAI1KMT2AMAPT | |
| SCHEMBL23067927 | 0.78 | CHRNB2 (0.74) | CHRNB2CHRNA4ORAI1KMT2A | |
| SCHEMBL4490294 | 0.78 | CHRNB2 (0.61) | CHRNB2CHRNA4ORAI1KMT2AMAPT | |
| SCHEMBL30756757 | 0.78 | CHRNB2 (0.74) | CHRNB2CHRNA4ORAI1KMT2A | |
| SCHEMBL31677378 | 0.77 | CHRNB2 (0.56) | CHRNB2CHRNA4ORAI1KMT2A | |
| SCHEMBL31742565 | 0.77 | CHRNB2 (0.65) | CHRNB2CHRNA4ORAI1 | |
| SCHEMBL43677 | 0.77 | KCNA3 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9115070-B2 | Process for preparing acrylic acid from ethylene oxide and carbon monoxide | BASF SE (DE) | 2015-08-25 | — | — | US | disclosed |
| US-20140018570-A1 | PROCESS FOR PREPARING ACRYLIC ACID FROM ETHYLENE OXIDE AND CARBON MONOXIDE | BASF SE (DE) | 2014-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140018570-A1 | PROCESS FOR PREPARING ACRYLIC ACID FROM ETHYLENE OXIDE AND CARBON MONOXIDE | HPD, HAAO, HAO2 | CHRNB2 2148/4885CHRNA4 1949/4885ORAI1 2136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.